A mutation in the p53 tumor suppressor gene of AHH-1 tk(+/-) human lymphoblastoid cells

被引:15
作者
Morris, SM
Manjanatha, MG
Shelton, SD
Domon, OE
McGarrity, LJ
Casciano, DA
机构
[1] Division of Genetic Toxicology, Natl. Ctr. for Toxicological Res., Dept. of Health and Human Services, Jefferson, AR 72079
[2] HFT-120/DGT/NCTR, Jefferson, AR 72079
关键词
AHH-1 tk(+/-) human lymphoblastoid cell; MCL-5 human lymphoblastoid cell; p53; mutation; CpG mutation;
D O I
10.1016/0027-5107(96)00133-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Loss-of-function mutations in the p53 tumor suppressor gene result in an altered response to DNA-damaging agents. Included in the mutant p53 phenotype are the loss of the G(1) checkpoint and delayed apoptotic cell death, characteristics we have consistently observed in the the AHH-1 tk(+/-) cell line following exposure to DNA-damaging agents. In order to determine the functional status of p53 in the AHH-1 tk(+/-) cell line, molecular analysis (single-strand conformational polymorphism [SSCP] and sequence analysis) was performed on exons 5-9 of the p53 gene. In addition, the status of the p53 gene in the closely related lymphoblast line, MCL-5, which, in our hands, has a much higher spontaneous rate of apoptosis than AHH-1 tk(+/-), was also determined by molecular analysis. Initial SSCP analysis of AHH-1 tk(+/-) revealed an abnormal migration pattern of exon 8 when compared to a wild-type control. Subsequent sequence analysis indicated that a base-pair substitution ((C) under bar GG --> (T) under bar GG) mutation had occurred at codon 282, a reported 'hot spot' for 5-methylcytosine mutations in the human p53 gene. Neither SSCP nor sequence analysis of exons 5-9 of MCL-5 indicated any differences from wild-type DNA. These results suggest that the lack of a G(1) arrest and the delayed entrance into apoptosis observed in chemically-exposed AHH-1 tk(+/-) cells are, at least partially, accounted for by a loss-of-function mutation in the p53 gene.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 34 条
[1]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[2]   A PROTEOLYTIC FRAGMENT FROM THE CENTRAL REGION OF P53 HAS MARKED SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY WHEN GENERATED FROM WILD-TYPE BUT NOT FROM ONCOGENIC MUTANT P53-PROTEIN [J].
BARGONETTI, J ;
MANFREDI, JJ ;
CHEN, XB ;
MARSHAK, DR ;
PRIVES, C .
GENES & DEVELOPMENT, 1993, 7 (12B) :2565-2574
[3]   INDUCTION OF APOPTOSIS BY TUMOR-SUPPRESSOR GENES AND ONCOGENES [J].
CANMAN, CE ;
KASTAN, MB .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (01) :17-25
[4]   SODIUM-FLUORIDE IS A LESS EFFICIENT HUMAN CELL MUTAGEN AT LOW CONCENTRATIONS [J].
CRESPI, CL ;
SEIXAS, GM ;
TURNER, T ;
PENMAN, BW .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1990, 15 (02) :71-77
[5]   A METABOLICALLY COMPETENT HUMAN CELL-LINE EXPRESSING 5 CDNAS ENCODING PROCARCINOGEN-ACTIVATING ENZYMES - APPLICATION TO MUTAGENICITY TESTING [J].
CRESPI, CL ;
GONZALEZ, FJ ;
STEIMEL, DT ;
TURNER, TR ;
GELBOIN, HV ;
PENMAN, BW ;
LANGENBACH, R .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (05) :566-572
[6]   ASSAY FOR GENE MUTATION IN A HUMAN LYMPHOBLAST LINE, AHH-1, COMPETENT FOR XENOBIOTIC METABOLISM [J].
CRESPI, CL ;
THILLY, WG .
MUTATION RESEARCH, 1984, 128 (02) :221-230
[7]   EXTENSIVE LOSS OF HETEROZYGOSITY ACCOUNTS FOR DIFFERENTIAL MUTATION-RATE ON CHROMOSOME 17Q IN HUMAN LYMPHOBLASTS [J].
DOBO, KL ;
GIVER, CR ;
EASTMOND, DA ;
RUMBOS, HS ;
GROSOVSKY, AJ .
MUTAGENESIS, 1995, 10 (01) :53-58
[8]   LI-FRAUMENI SYNDROME FIBROBLASTS HOMOZYGOUS FOR P53 MUTATIONS ARE DEFICIENT IN GLOBAL DNA-REPAIR BUT EXHIBIT NORMAL TRANSCRIPTION-COUPLED REPAIR AND ENHANCED UV RESISTANCE [J].
FORD, JM ;
HANAWALT, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8876-8880
[9]   P53 MUTATIONS IN HUMAN LYMPHOID MALIGNANCIES - ASSOCIATION WITH BURKITT-LYMPHOMA AND CHRONIC LYMPHOCYTIC-LEUKEMIA [J].
GAIDANO, G ;
BALLERINI, P ;
GONG, JZ ;
INGHIRAMI, G ;
NERI, A ;
NEWCOMB, EW ;
MAGRATH, IT ;
KNOWLES, DM ;
DALLAFAVERA, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5413-5417
[10]  
GREENBLATT MS, 1994, CANCER RES, V54, P4855